(Q30371076)

English

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. (English)

1 reference

Europe PubMed Central

8 November 2017

type-1 diabetes

0 references

1

object named as

Jan Skupien

1 reference

Europe PubMed Central

8 November 2017

Maciej T Malecki

5

object named as

Maciej Malecki

1 reference

Europe PubMed Central

8 November 2017

2

object named as

James H Warram

1 reference

Europe PubMed Central

8 November 2017

Andrzej S. Krolewski

8

object named as

Andrzej S Krolewski

1 reference

Europe PubMed Central

8 November 2017

Monika Niewczas

3

object named as

Monika A Niewczas

1 reference

Europe PubMed Central

8 November 2017

author name string

Tomohito Gohda

4

1 reference

Europe PubMed Central

8 November 2017

Josyf C Mychaleckyj

6

1 reference

Europe PubMed Central

8 November 2017

Andrzej T Galecki

7

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

4 June 2014

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

37

1 reference

Europe PubMed Central

8 November 2017

9

1 reference

Europe PubMed Central

8 November 2017

2601-2608

1 reference

Europe PubMed Central

8 November 2017

Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Risk for ESRD in type 1 diabetes remains high despite renoprotection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Joint modelling of longitudinal measurements and event time data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Testing for differences in changes in the presence of censoring: parametric and non-parametric methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

3 June 2018

Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140154

26 November 2018

Identifiers

10.2337/DC13-1983

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30371076&oldid=2126433599"